Simard François, Gauthier Charles, Legault Jean, Lavoie Serge, Mshvildadze Vakhtang, Pichette André
Laboratoire LASEVE, Département des Sciences Fondamentales, Université du Québec à Chicoutimi, 555, boul. de l'Université, Chicoutimi (Québec) G7H 2B1, Canada.
Laboratoire LASEVE, Département des Sciences Fondamentales, Université du Québec à Chicoutimi, 555, boul. de l'Université, Chicoutimi (Québec) G7H 2B1, Canada; INRS-Institut Armand-Frappier, Université du Québec, 531 boul. des Prairies, Laval (Québec) H7V 1B7, Canada.
Bioorg Med Chem. 2016 Sep 15;24(18):4188-4198. doi: 10.1016/j.bmc.2016.07.009. Epub 2016 Jul 6.
There is nowadays an urgent need for developing novel generations of antibiotic agents due to the increased resistance of pathogenic bacteria. As a rich reservoir of structurally diverse compounds, plant species hold promise in this regard. Within this framework, we isolated a unique series of antibacterial flavonoids, named balsacones N-U, featuring multiple cinnamyl chains on the flavan skeleton. The structures of these compounds, isolated as racemates, were determined using extensive 1D and 2D NMR analysis in tandem with HRMS. Balsacones N-U along with previously isolated balsacones A-M were evaluated for their antibacterial activity against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA). Several of the tested balsacones were potent anti-MRSA agents showing MIC values in the low micromolar range. Structure-activity relationships study highlighted some important parameters involved in the antibacterial activity of balsacones such as the presence of cinnamyl and cinnamoyl chains at the C-3 and C-8 positions of the flavan skeleton, respectively. These results suggest that balsacones could represent a potential novel class of naturally occurring anti-MRSA agents.
由于致病细菌的耐药性增加,目前迫切需要开发新一代的抗生素药物。作为结构多样化合物的丰富来源,植物物种在这方面具有潜力。在此框架下,我们分离出了一系列独特的抗菌黄酮类化合物,命名为balsacones N-U,其在黄烷骨架上具有多个肉桂基链。这些作为外消旋体分离得到的化合物的结构,通过广泛的一维和二维核磁共振分析并结合高分辨质谱来确定。对balsacones N-U以及先前分离出的balsacones A-M针对耐甲氧西林金黄色葡萄球菌(MRSA)临床分离株的抗菌活性进行了评估。几种测试的balsacones是强效的抗MRSA药物,其最低抑菌浓度(MIC)值在低微摩尔范围内。构效关系研究突出了一些参与balsacones抗菌活性的重要参数,例如分别在黄烷骨架的C-3和C-8位置存在肉桂基和肉桂酰基链。这些结果表明,balsacones可能代表一类潜在的新型天然抗MRSA药物。